CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Lidocaine Hydrochloride Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current, To Be Discontinued. First FDA posting: 2012-02-22. Latest FDA row update: 2026-10-05.
FDA lists 67 package records, with companies: Amphastar Pharmaceuticals, Inc., Anthea Pharma, Avenacy, LLC, B. Braun Medical Inc., Baxter Healthcare, Baxter Healthcare Corporation, Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals USA, Inc., Hospira, Inc., Hospira, Inc., a Pfizer Company, Huons Co., Ltd., Huons Co., Ltd. (South Korea), International Medication Systems, Limited, Spectra Medical Devices, LLC. Package NDCs: 0143-9575-10, 0143-9577-10, 0143-9594-25, 0143-9595-25, 0264-9594-10, 0264-9594-20, 0264-9598-20, 0338-0409-03, 0338-0411-02, 0409-1323-05, 0409-2066-05, 0409-4275-01, 0409-4276-01, 0409-4276-02, 0409-4277-01, 0409-4277-02, 0409-4278-01, 0409-4279-02, 0409-4282-01, 0409-4282-02, 0409-4283-01, 0409-4713-02, 0409-4713-32, 0409-4776-01, 0409-4903-34, 0409-4904-34, 0409-9137-05, 55150-159-74, 55150-161-02, 55150-162-05, 55150-163-30, 55150-164-02, 55150-165-05, 55150-251-10, 55150-252-20, 55150-254-10, 55150-255-20, 55150-256-50, 63323-201-02, 63323-201-10, 63323-202-02, 63323-208-05, 63323-484-57, 63323-485-27, 63323-485-57, 63323-486-17, 63323-486-27, 63323-486-57, 63323-491-57, 63323-492-27, 63323-492-31, 63323-492-37, 63323-492-57, 63323-493-91, 63323-493-97, 63323-495-07, 63323-495-27, 63323-496-97, 65282-1605-1, 73293-0001-2, 76329-3390-1, 83634-651-10, 83634-651-20, 83634-651-50, 83634-653-02, 83634-653-05, 83634-653-30.
FDA shortage reason: Demand increase for the drug; Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. | 76329-3390-1 | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Limited Availability | 2026-09-16 |
| Anthea Pharma | 83634-653-05 | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Available | 2026-10-05 |
| Anthea Pharma | 83634-651-10 | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Available | 2026-10-05 |
| Anthea Pharma | 83634-653-02 | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Available | 2026-10-05 |
| Anthea Pharma | 83634-651-20 | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Available | 2026-10-05 |
| Anthea Pharma | 83634-653-30 | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Available | 2026-10-05 |
| Anthea Pharma | 83634-651-50 | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Available | 2026-10-05 |
| B. Braun Medical Inc. | 0264-9594-10 | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-9594-20 | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-9598-20 | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | Available | 2026-09-22 |
| Baxter Healthcare | 0338-0409-03 | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0411-02 | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Available | 2026-10-02 |
| Eugia US LLC | 55150-159-74 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-161-02 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-162-05 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Available | 2026-10-02 |
| Eugia US LLC | 55150-163-30 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Available | 2026-10-02 |
| Eugia US LLC | 55150-251-10 | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-252-20 | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Available | 2026-10-02 |
| Eugia US LLC | 55150-165-05 | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-164-02 | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Available | 2026-10-02 |
| Eugia US LLC | 55150-254-10 | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Unavailable | 2026-10-02 |
| Eugia US LLC | 55150-255-20 | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Available | 2026-10-02 |
| Eugia US LLC | 55150-256-50 | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Unavailable | 2026-10-02 |
| Fresenius Kabi USA, LLC | 63323-201-02 | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-208-05 | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-201-10 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-202-02 | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-485-27 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-485-57 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-492-27 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-492-31 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-492-37 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-492-57 | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-493-91 | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-493-97 | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-486-17 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-486-27 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-486-57 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-495-07 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-495-27 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-496-97 | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-484-57 | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-491-57 | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Available | 2026-09-15 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9577-10 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Available | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9575-10 | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Available | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9595-25 | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Available | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9594-25 | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Available | 2026-09-18 |
| Hospira, Inc., a Pfizer Company | 0409-4277-02 | Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4276-01 | Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4275-01 | Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) | Unavailable | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4277-01 | Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4276-02 | Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-1323-05 | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-9137-05 | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4713-32 | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4283-01 | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4776-01 | Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4713-02 | Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4904-34 | Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)" | Not stated | 2025-11-07 |
| Hospira, Inc., a Pfizer Company | 0409-2066-05 | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4903-34 | Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)" | Not stated | 2025-11-07 |
| Hospira, Inc., a Pfizer Company | 0409-4282-02 | Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4278-01 | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4279-02 | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-4282-01 | Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Available | 2026-09-22 |
| Huons Co., Ltd. (South Korea) | 73293-0001-2 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Unavailable | 2026-07-30 |
| Spectra Medical Devices, LLC | 65282-1605-1 | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) | Unavailable | 2026-05-15 |
Source facts
Grouped generic ingredient: Lidocaine Hydrochloride Injection · 67 package records
Therapeutic categories: Analgesia/Addiction, Anesthesia, Cardiovascular, Pediatric
Dosage forms: Injection
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, INTRAVENOUS, PERINEURAL, RETROBULBAR, TOPICAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.